EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report

Lineage transformation from lung adenocarcinoma (LUAD) to SCLC is associated with resistance to EGFR tyrosine kinase inhibitors. In addition to loss of p53 and RB, transformed SCLCs are usually not dependent on EGFR signaling, which renders the tumors unresponsive to EGFR tyrosine kinase inhibitors....

Descripción completa

Detalles Bibliográficos
Autores principales: Takuma, Sho, Inoue, Yusuke, Karayama, Masato, Tsuchiya, Kazuo, Tsukui, Hiroe, Hozumi, Hironao, Suzuki, Yuzo, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Nakamura, Yutaro, Inui, Naoki, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718492/
https://www.ncbi.nlm.nih.gov/pubmed/35005656
http://dx.doi.org/10.1016/j.jtocrr.2021.100264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718492/
https://www.ncbi.nlm.nih.gov/pubmed/35005656
http://dx.doi.org/10.1016/j.jtocrr.2021.100264

Ejemplares similares